Sign in to continue:

Wednesday, July 29th, 2026

安徽皖维高新收购进展:海螺集团获反垄断审查通过并将成间接控股股东

皖维高新材料收购进展公告详解 —— 重大股权变动及反垄断审查最新进展

皖维高新材料收购进展公告详解 —— 重大股权变动及反垄断审查最新进展

一、事件概述

安徽皖维高新材料股份有限公司(皖维高新,证券代码:600063)于2026年6月12日发布重大进展公告,通报海螺集团通过现金增资及安徽省投资集团、安徽省国有资本运营集团通过无偿划转方式,拟合计间接控制公司33.24%表决权股份的重大重组事项,并获得国家市场监督管理总局的反垄断审查通过。这一系列动作将导致公司实际控制权结构发生重大变化,具备显著的潜在市值影响。

二、关键交易结构与内容

  • 海螺集团现金增资: 海螺集团计划以现金方式向安徽皖维集团增资49.98亿元,获得其60%股权,从而间接持有皖维高新18.24%的股份。
  • 国有资本划转: 安徽省投资集团控股有限公司、省国有资本运营控股集团有限公司将通过无偿划转方式分别获得皖维集团20%的股权、皖维高新7.5%的股份。三方构成一致行动人,合计控制皖维高新33.24%的表决权股份。
  • 控股权结构变化: 重组完成后,皖维集团仍为皖维高新的控股股东,海螺集团将成为间接控股股东,公司的实际控制人仍为安徽省人民政府国资委。
  • 相关公告与信息披露: 相关细节已在2026年1月30日、2月6日的公告中披露,包括收购报告书及控股权变动提示。

三、监管审批最新进展

  • 反垄断审查通过: 2026年6月10日,国家市场监督管理总局出具《经营者集中反垄断审查不予禁止决定书》,正式批准本次收购案实施。这意味着监管层面最大的不确定性已消除,为交易顺利推进扫清障碍。
  • 后续流程与风险提示: 该收购事项仍需上海证券交易所合规审查确认,并在中国证券登记结算有限责任公司上海分公司办理股份过户登记等手续。最终能否全部顺利完成仍存在不确定性,投资者需注意相关风险。

四、对投资者的影响与潜在价值变动因素

  • 公司控制权变更: 通过引入海螺集团等大型国资背景股东,有望增强公司资本实力、产业协同与治理结构完善,提升公司综合竞争力和市场影响力。
  • 国有资本整合预期: 皖维高新成为安徽省重点国有资本运营平台之一,未来在政策、资金和产业整合上有望获得更多资源倾斜,有助于公司做大做强。
  • 监管审批通过释放利好: 反垄断审查顺利通过,意味着监管层面对本次重组的认可,消除市场主要的不确定性,有望带动市场信心与估值修复。
  • 后续不确定性需关注: 股东变更及股份过户仍需后续合规流程,任何超预期变化均可能影响公司股价表现,投资者应持续关注公司后续公告。

五、结论

本次收购事项涉及重大股权和控制权变动,相关审批进展及国有资本整合预期均构成潜在股价催化剂。建议投资者密切关注后续过户流程及公司公告,把握投资机会,注意风险防范。


免责声明: 本文内容仅作为信息披露解读,不构成任何投资建议。投资者应根据自身情况、结合公司后续公告及市场变化,做出独立判断与决策。


English Version
Detailed Progress Update on Wanwei Gaoxin’s Acquisition – Major Shareholding Change and Latest Antitrust Approval

Detailed Progress Update on Wanwei Gaoxin’s Acquisition – Major Shareholding Change and Latest Antitrust Approval

1. Event Overview

Anhui Wanwei Gaoxin Materials Co., Ltd. (Wanwei Gaoxin, Stock Code: 600063) released a major progress announcement on June 12, 2026. The announcement details that Conch Group will indirectly control 33.24% of the company’s voting shares through a cash capital increase and the free transfer of shares by Anhui Provincial Investment Group and Anhui State-owned Capital Operation Group. The deal has received antitrust approval from the State Administration for Market Regulation, signaling a significant change in the company’s actual control structure and potentially impacting its market value.

2. Key Transaction Structure and Details

  • Conch Group Cash Injection: Conch Group plans to inject RMB 4.9982 billion in cash into Wanwei Group, obtaining 60% of its equity and indirectly holding 18.24% of Wanwei Gaoxin’s shares.
  • State-owned Capital Transfer: Anhui Provincial Investment Group and Anhui State-owned Capital Operation Group will acquire 20% each of Wanwei Group’s equity and 7.5% each of Wanwei Gaoxin’s shares through free transfer. Acting in concert, the three parties will control 33.24% of Wanwei Gaoxin’s voting shares.
  • Changes in Control Structure: Upon completion, Wanwei Group remains the controlling shareholder of Wanwei Gaoxin, while Conch Group becomes the indirect controlling shareholder. The company’s de facto controller remains the Anhui SASAC.
  • Disclosure of Related Announcements: Details were previously disclosed on January 30 and February 6, 2026, including the acquisition report and controlling equity change notice.

3. Latest Regulatory Progress

  • Antitrust Approval: On June 10, 2026, the State Administration for Market Regulation officially approved the acquisition, issuing a “No Prohibition Decision on Concentration of Undertakings” and clearing the main regulatory hurdle for the transaction.
  • Subsequent Procedures and Risks: The acquisition is still subject to compliance review by the Shanghai Stock Exchange and share transfer registration at China Securities Depository and Clearing Corporation. The final completion remains uncertain, and investors are advised to be mindful of the associated risks.

4. Impact on Investors and Potential Value Drivers

  • Change of Control: Introducing key state-owned shareholders such as Conch Group is expected to enhance capital strength, industrial synergy, and corporate governance, thereby boosting competitiveness and market influence.
  • SOE Capital Consolidation Expectation: Wanwei Gaoxin becomes a key SOE operation platform in Anhui, with potential access to more policy, funding, and industrial integration support.
  • Regulatory Approval as a Positive Catalyst: Successful antitrust review eliminates a major uncertainty, likely to boost market confidence and support a valuation recovery.
  • Ongoing Uncertainties: Shareholder changes and share transfer are still pending compliance procedures; any unexpected developments may affect share price performance. Investors should monitor subsequent disclosures closely.

5. Conclusion

This acquisition involves significant changes in shareholding and control, with antitrust approval and state capital consolidation expectations serving as potential share price catalysts. Investors are advised to closely follow subsequent procedures and company announcements while managing risks.


Disclaimer: This article is for information disclosure interpretation only and does not constitute any investment advice. Investors should make independent judgments and decisions based on their circumstances, company follow-up disclosures, and market changes.


View 皖维高新 Historical chart here



山西兰花科技创业股份有限公司2026年第一季度报告:营收增长9.94%,净利润大幅下滑

山西兰花科技创业股份有限公司2026年第一季度报告分析 山西兰花科技创业股份有限公司2026年第一季度财报详解 一、...

海南矿业收购洛阳丰瑞氟业69.90%股权交易不构成重组上市——独立财务顾问核查意见

海南矿业重大资产重组核查意见详解 海南矿业并购洛阳丰瑞氟业69.90%股权:不构成重组上市,实控人未变 主要内容摘要...

艾为电子发布可转债投资者适当性要求及转股风险提示公告(2026)

艾为电子关于可转债投资者适当性要求的风险提示详细分析 艾为电子关于可转债投资者适当性要求的风险提示性公告——投资者详...